Related Experiment Videos
Serratia marcescens endocarditis treated with ceftazidime. A case report
Summary
A rare case of Serratia marcescens endocarditis in a teenage girl, resistant to initial treatments, was successfully managed. The infection was ultimately cured with a new cephalosporin antibiotic and valve replacement.
Area of Science:
- Infectious Diseases
- Cardiology
- Pharmacology
Background:
- Serratia marcescens is an opportunistic pathogen that can cause serious infections, including endocarditis.
- Endocarditis following cardiac surgery, particularly valve repair, presents a significant clinical challenge.
Observation:
- A 14-year-old Black female developed Serratia marcescens endocarditis post-mitral valve repair.
- The patient's condition was refractory to multiple antibiotic regimens and an initial valve replacement.
Findings:
- Successful treatment was achieved with a second valve replacement and the administration of ceftazidime, a novel cephalosporin derivative.
- Ceftazidime demonstrated efficacy in eradicating the resistant Serratia marcescens infection.
Implications:
- This case highlights the potential utility of ceftazidime in managing refractory bacterial endocarditis.
- It underscores the importance of considering novel antibiotic agents and surgical intervention for complex cardiovascular infections.